Concepedia

Meredith A. Miller

MA

Statistics

Publications

6

Citations

940

H-Index

6

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Meredith A. Miller is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, pharmacology, and life sciences.

Publications per year

2017–2021

6

Publications

6

Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40

Haijuan Yang, Xiaolu Jiang, Buren Li et al. · Nature · 2017 · 542 citations · Full text

, , +8

Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib

Yuting Sun, Brooke A. Meyers, Barbara Czakó et al. · Cancer Research · 2020 · 106 citations · Full text

, , +17

Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties

Michael Soth, Kang Le, Maria Emilia Di Francesco et al. · Journal of Medicinal Chemistry · 2020 · 91 citations · Full text

, , +16

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma

Virginia Giuliani, Meredith A. Miller, Chiu-Yi Liu et al. · Nature Communications · 2021 · 78 citations · Full text

, , +17

Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation

Yuting Sun, Madhavi Bandi, Timothy Lofton et al. · Cell Reports · 2019 · 67 citations · Full text

, , +17

1–5 of 6